RxDoctor Payments DataLook up a doctor →

Vijayendra Verma, MD

Cardiovascular Disease · Haddon Heights, NJNPI 1275585846

Payments from drug & device makers

$359,027in general payments, 2019–2025

Across 624 payments — averaging $575.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • CSL Behring$207K
  • Abbott$88K
  • AstraZeneca$20K
  • Boehringer Ingelheim Pharma GmbH & Co.kg$20K
  • Cordis Corporation$13K
  • Boehringer Ingelheim International GmbH$5K
  • plus $6K from 47 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
CSL Behring99$207,235
Abbott202$87,863
AstraZeneca55$20,425
Boehringer Ingelheim Pharma GmbH & Co.kg2$19,518
Cordis Corporation6$12,623
Boehringer Ingelheim International GmbH1$5,000
Medtronic(2 entities)12$756
Edwards Lifesciences12$620
Amgen39$506
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)34$485
E.r. Squibb & Sons, L.L.C.17$336
Boston Scientific5$318
Abiomed7$318
Johnson & Johnson20$282
Boehringer Ingelheim6$222
Novartis13$216
Novo Nordisk7$191
Bayer4$176
Pfizer11$165
Philips North America LLC1$150
Esperion Therapeutics, Inc.3$134
Getinge USA Sales, LLC2$126
Impulse Dynamics (USA) Inc.5$126
Bard Peripheral Vascular, Inc.3$96
W. L. Gore & Associates, Inc.4$94
Amarin Pharma, Inc.7$91
Cardiovascular Systems Inc.6$89
Penumbra, Inc.3$86
Atricure, Inc.2$83
Shockwave Medical, Inc1$76
Angiodynamics, Inc.3$59
Merck4$56
Sanofi-aventis U.S. LLC4$56
Biotronik Inc.1$42
Inspire Medical Systems, Inc.2$37
Cardinal Health 200 LLC2$33
Tactile Systems Technology Inc1$28
Kiniksa Pharmaceuticals International, PLC2$28
Chiesi USA, Inc.1$27
Baxter Healthcare1$26
Cardiva Medical, Inc.1$25
Kiniksa Pharmaceuticals, Ltd.2$25
Biogen1$24
Cordis US CORP.1$22
Stryker1$17
Regeneron1$17
Daiichi Sankyo Inc.1$16
Bridgebio Pharma, Inc.1$16
Actelion Pharmaceuticals US, Inc.1$15
Astellas Pharma US Inc1$14
Otsuka America Pharmaceutical, Inc.1$13
Acarix USA Inc.1$13
Kowa Pharmaceuticals America, Inc.1$12

How this compares

$359,027 in reported general payments places this provider in the 95th percentile of 1,006 cardiovascular disease providers in New Jersey.

See all cardiovascular disease providers in New Jersey →

Medicare billing

Part B allowed, 2024
$1,110,537
Medicare patients
961
Services billed
3,120

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Haddon Heights

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →